EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anticholinergic Medication Use in Veterans Affairs Long‐Term Care Residents: Clinical Patterns and Opportunities for Deprescribing

Cellas A Hayes iD, Yongmei Li, Bocheng Jing, Laura A Graham, Chintan Dave, Michelle C Odden iD

Journal of the American Geriatrics Society · 2026

DOI: 10.1111/jgs.70570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2026. Verfasst von Cellas A Hayes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Deprescriptions, Long-Term Care, Veterans. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Burroughs Wellcome Fund Postdoctoral Enrichment Program, NIH NIA Health Enhancement Scientific Program, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anticholinergic exposure is common in nursing homes; however, the true burden may be underestimated, particularly due to over‐the‐counter agents such as first‐generation antihistamines that are not consistently captured in prior claims‐based studies. This gap limits accurate characterization of anticholinergic use and its clinical implications in older adults. Participants and Setting Veterans aged ≥ 65 years with stays ≥ 90 days ( N = 45,183) residing in US Department of Veterans Affairs (VA) Community Living Centers (CLC). This study is a secondary data analysis of residents identified during fiscal years 2007–2019.

Methods

True anticholinergic exposure through barcode‐based medication administration dispensing records allowed daily measurement of anticholinergic exposure, with follow‐up extending from admission to discharge, death, or April 1, 2025. Anticholinergic medication use was defined as use ≥ 4 days per week during the CLC stay. Drugs were identified using VA classifications aligned with the 2023 American Geriatrics Society Beers Criteria and grouped into nine anticholinergic classes. Outcomes included prevalence, duration, and number of anticholinergic drug classes used; patterns by dementia status; and temporal trends over time.

Results

Among 45,183 CLC residents, 33.4% ( n = 15,074) used anticholinergic medications. Residents with dementia ( n = 20,254) showed substantial exposure to neuropsychiatric anticholinergics, including second‐generation antipsychotics (30.6%) and antiparkinsonian agents (10.1%). First‐generation antihistamine use remained high in this group (29.5%). Residents without dementia ( n = 24,929) more frequently received antihistamines (34.4%), bladder antimuscarinics (23.7%), and skeletal muscle relaxants (11.1%). From FY2007–2019, anticholinergic use declined modestly, with decreases in antihistamines (12.1%–8.8%), antidepressants (6.8%–3.5%), and antiemetic/antivertigo agents (5.2%–1.2%). Most residents used a single anticholinergic class, increasing from 75.5% to 82.2% over time.

Conclusions

Although some anticholinergic classes may be clinically necessary, our findings highlight potentially underrecognized and modifiable sources of exposure, particularly first‐generation antihistamines, underscoring the need for deprescribing efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinergic AntagonistsDeprescriptionsLong-Term CareVeteransPractice Patterns, Physicians'HumansUnited StatesMaleFemaleAgedNursing Home ResidentsAged, 80 and overUnited States Department of Veterans AffairsNursing Homes

Stichwörter der Autor:innen

anticholinergic medicationsdementiadeprescribinglong‐term carethe American Geriatrics Society (AGS) Beers Criteria

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA.
  • Health Economics Resource Center, VA Palo Alto Health Care System, Palo Alto, California, USA.
  • Center for Health Outcomes, Policy, and Economics, College of Pharmacy, Rutgers University, New Brunswick, New Jersey, USA.
  • Center for Pharmacoepidemiology and Treatment Sciences, Institute for Health, Rutgers University, New Brunswick, New Jersey, USA.

ORCID-Profile: Cellas A Hayes, Michelle C Odden

Förderung

  • Burroughs Wellcome Fund Postdoctoral Enrichment Program
  • NIH NIA Health Enhancement Scientific Program
  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Hayes, C. A., Li, Y., Jing, B., Graham, L. A., Dave, C., & Odden, M. C. (2026). Anticholinergic Medication Use in Veterans Affairs Long‐Term Care Residents: Clinical Patterns and Opportunities for Deprescribing. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.70570

Vancouver

Hayes CA, Li Y, Jing B, Graham LA, Dave C, Odden MC. Anticholinergic Medication Use in Veterans Affairs Long‐Term Care Residents: Clinical Patterns and Opportunities for Deprescribing. Journal of the American Geriatrics Society. 2026. doi:10.1111/jgs.70570

BibTeX
@article{Hayes2026,
  author = {Hayes, Cellas A and Li, Yongmei and Jing, Bocheng and Graham, Laura A and Dave, Chintan and Odden, Michelle C},
  title = {Anticholinergic Medication Use in Veterans Affairs Long‐Term Care Residents: Clinical Patterns and Opportunities for Deprescribing},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  doi = {10.1111/jgs.70570}
}
Kostenlos starten →